Chronic Non-A, Non-B, Non-C Hepatitis: Is Hepatitis G/GBV-C Involved?

References

• Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, et al. Hepatitis C virus infection in posttransfusion hepatitis. N Engl J Med 1991; 325: 1325–9
   PubMed Web of Science ®Google Scholar
• Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo Q-L, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494–500
   PubMed Web of Science ®Google Scholar
• Esteban JI, Gonzalez A, Hernández JM, Viladomiul L, Sanchez C, Lopez-Talavera JL, et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990; 323: 1107–12
   PubMed Web of Science ®Google Scholar
• Koretz RL, Brezina M, Polito AJ, Quan S, Wilber J, Dinello R, et al. Non-A non-B posttransfusion hepatitis: comparing C and non-C hepatitis. Hepatology 1993; 17: 361–5
   PubMed Web of Science ®Google Scholar
• Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, et al. Long-term follow-up of non-A, non-B (type C) posttransfusion hepatitis. J Hepatol 1992; 16: 273–81
   PubMed Web of Science ®Google Scholar
• Tanaka E, Kiyosawa K, Sodeyama T, Nakano Y, Yoshizawa K, Hayata T, et al. Significance of antibody to hepatitis C virus in Japanese patients with viral hepatitis: Relationship between anti-HCV antibody and the prognosis of non-A, non-B posttransfusion hepatitis. J Med Virol 1991; 33: 117–22
   PubMed Web of Science ®Google Scholar
• Navascues CA, Rodriguez M, Sotorrio NG, Leiva P, Martinez A, Perez R, et al. Epidemiological, clinical and biological characteristics of acute non-A, non-B hepatitis with and without hepatitis C virus infection. Infection 1994; 22: 252–7
   PubMed Web of Science ®Google Scholar
• Azar N, Valla D, Lunel D, Fretz C, Mallet A, Jaulmes D, et al. Post-transfusional anti-HCV-negative, non-A, non-B hepatitis. I. A prospective clinical and epidemiological survey. J Hepatol 1993; 18: 24–33
   PubMed Web of Science ®Google Scholar
• Tassopoulos NC, Hatzakis A, Kuhns M, Miriagou V, Delladetsima I, Koutelou MG, . Clinical and laboratory features of acute community acquired non-A, non-B, non-C-hepatitis. Viral hepatitis and liver disease, K Nishioka, H Suzuki, S Mishiro, T Oda, et al. Springer-Verlag, Tokyo 1994; 80–4
   Google Scholar
• Buti M, Jardi R, Rodriguez-Frias F, Quer J, Esteban R, Guardia J. Etiology of acute sporadic hepatitis in Spain: the role of hepatitis C and E viruses. J Hepatol 1994; 20: 589–92
   PubMed Web of Science ®Google Scholar
• Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899–905
   PubMed Web of Science ®Google Scholar
• Jeffers LJ, Hasan F, De Medina M, Reddy R, Parker T, Silva M, et al. Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis. Hepatology 1992; 15: 187–90
   PubMed Web of Science ®Google Scholar
• Brown J, Dourakis S, Karayiannis P, Goldin R, Chiba J, Ohba H, et al. Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease. Hepatology 1992; 15: 175–9
   PubMed Web of Science ®Google Scholar
• Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GC, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Medicine 1995; 1: 564–9
   PubMed Web of Science ®Google Scholar
• Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131–2
   PubMed Web of Science ®Google Scholar
• Linnen J, Wages J, Jr, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505–8
   PubMed Web of Science ®Google Scholar
• Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485–90
   PubMed Web of Science ®Google Scholar
• Leary TP, Muerhoff AS, Simons JN, Piolot-Matias TJ, Erker JC, Chalmers ML, et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996; 48: 60–7
   PubMed Web of Science ®Google Scholar
• Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Biischenfelde KH. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987; 1: 292–4
   PubMed Web of Science ®Google Scholar
• Homberg J-C, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, et al. Chronic active hepatitis associated with anti liver kidney microsome antibody type 1: a second type of ‘autoimmune’ hepatitis. Hepatology 1987; 7: 1333–9
   PubMed Web of Science ®Google Scholar
• Wejstål R, Hermodsson S, Norkrans G. Long-term follow-up of chronic hepatitis non-A, non-B -with special reference to hepatitis C. Liver 1991; 11: 143–8
   PubMedGoogle Scholar
• Widell A, Månsson AS, Sundström G, Hansson BG, Nordenfelt E. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: Comparison with supplementary hepatitis C antibody assays. J Med Virol 1991; 35: 253–8
   PubMed Web of Science ®Google Scholar
• Lindh M, Furuta Y, Kidd Ljunggren K, Norkrans G, Horal P. Detection of hepatitis B virus precore TAG mutant by an amplification created restriction site method. J Infect Dis 1995; 171: 194–7
   PubMed Web of Science ®Google Scholar
• An International Group. Acute and chronic hepatitis revisited [review]. Lancet 1977; 2: 914–9
   PubMed Web of Science ®Google Scholar
• Mc Hutchison JG, Person JL, Govindarajan S, Valinluck B, Gore T, Lee SR, et al. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology 1992; 15: 19–25
   PubMed Web of Science ®Google Scholar
• Nishiguchi S, Kuroki T, Ueda T, Fukuda K, Takeda T, Nakajima S, et al. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Ann Intern Med 1992; 116: 21–5
   PubMed Web of Science ®Google Scholar
• Silva AE, Hosein B, Boyle RW, Fang CT, Shindo M, Waggoner JG, et al. Diagnosis of chronic hepatitis C: comparison of immuno-assays and the polymerase chain reaction. Am J Gastroenterol 1994; 89: 493–6
   PubMed Web of Science ®Google Scholar
• Uyttendaele S, Claeys H, Mertens W, Verhaert H, Vermylen C. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994; 66: 122–9
   PubMed Web of Science ®Google Scholar
• Fried MW, Draguesku JO, Shindo M, Simpson LH, Banks SM, Hoofnagle JH, et al. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis. Dig Dis Sci 1993; 38: 631–6
   PubMed Web of Science ®Google Scholar
• Rowan BP, Smith A, Gleeson D, Hunt LP, Warnes TW. Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact?. Gut 1994; 35: 542–6
   PubMed Web of Science ®Google Scholar
• Garson JA, Lenzi M, Ring F, Cassani F, Ballardini G, Briggs M, et al. Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol 1991; 34: 223–6
   PubMed Web of Science ®Google Scholar
• Dienstag JL, Katkov WN, Cody H. Evidence for non-A, non-B hepatitis agents besides hepatitis C virus. Viral hepatitis and liver disease, FB Hollinger, SM Lemon, HS Margolis. Williams & Wilkins, Baltimore 1991; 349–56
   Google Scholar
• Chemello L, Cavaletto D, Pontisso P, Bortolotti F, Donada C, Donadon V, et al. Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. Hepatology 1993; 17: 179–82
   PubMed Web of Science ®Google Scholar